scholarly journals Targeting cancer prevention and screening interventions to LGBTQ communities: A scoping review

2020 ◽  
Author(s):  
Kerryn Drysdale ◽  
Elena Cama ◽  
Jessica Botfield ◽  
Brandon Bear ◽  
Rebecca Cerio ◽  
...  
Keyword(s):  
Cancer Prevention ◽  
Scoping Review ◽  
Cancer Prevention And Screening

The Influence of Health Literacy on Knowledge of Cervical Cancer Prevention and Screening Practices among Female Undergraduates at a University in Southwest Nigeria

2020 ◽  
Vol 22 (1) ◽  
Author(s):  
Sunday Joseph Ayamolowo ◽  
Lydia Feyisayo Akinrinde ◽  
Monisola Omoyeni Oginni ◽  
Love Bukola Ayamolowo
Keyword(s):  
Cervical Cancer ◽  
Health Literacy ◽  
Cancer Screening ◽  
Cancer Prevention ◽  
Cervical Cancer Screening ◽  
Low Income ◽  
Cervical Cancer Prevention ◽  
Screening Practices ◽  
Cancer Prevention And Screening ◽  
Southwest Nigeria

The global incidence of cancer is rising, and low-income and lower-middle-income countries have the worst figures. However, knowledge of cervical cancer prevention and cervical cancer screening practices remains poor in these regions. This study assessed the concept of health literacy as a potential determinant of knowledge of cervical cancer prevention and screening practices among female undergraduates. A descriptive cross-sectional study was conducted among 385 female undergraduates at a university in southwest Nigeria. A validated questionnaire composed of subscales on nine components of health literacy, knowledge of cervical cancer prevention, and cervical cancer screening practices was used for data collection. The majority of the respondents obtained a high score on most of the components of health literacy and 66% had good knowledge of cervical cancer prevention. Only 11% demonstrated good practices of Pap smear testing. Of all the components of health literacy, “feeling understood and supported by healthcare providers” (OR = 0.075; 95% CI [0.036–0.115]; p = 0.015) and “understanding health information well enough to know what to do” (OR = 0.055; 95% CI [0.006–0.104]; p = 0.029) were significantly associated with knowledge of cervical cancer prevention. Out of the major challenges related to cervical cancer screening among undergraduates, the feeling of being at risk (OR = 4.71; p < 0.05) and uncomfortable experiences from past screening (OR = 0.12; p < 0.05) were significantly associated with going for cervical cancer screening. The study concluded that levels of health literacy influenced knowledge of cervical cancer prevention among female undergraduates, but it did not affect their engagement in cervical cancer screening practices.

scholarly journals Ovarian cancer prevention and screening

2018 ◽  
pp. 331-348
Author(s):  
Aleksandra Gentry‐Maharaj ◽  
Michelle Griffin ◽  
Usha Menon
Keyword(s):  
Ovarian Cancer ◽  
Cancer Prevention ◽  
Cancer Prevention And Screening

Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention

2018 ◽  
pp. 101-109 ◽  
Author(s):  
Matthew B. Yurgelun ◽  
Heather Hampel
Keyword(s):  
Lynch Syndrome ◽  
Cancer Prevention ◽  
Checkpoint Inhibitors ◽  
Tremendous Progress ◽  
Cancer Prevention And Screening ◽  
Reduction Strategies ◽  
Neoplastic Process ◽  
Risk Reduction Strategies ◽  
Next Generation Sequencing Ngs ◽  
Generation Sequencing

Identification of individuals with inherited predispositions to cancer, including Lynch syndrome, can help prevent cancer and cancer-related death by allowing for the uptake of specific cancer prevention and screening as well as the use of therapies directed toward the underlying neoplastic process for individuals with advanced cancer. In the 25 years since the discovery of microsatellite instability (MSI) and the first recognition of germline mismatch repair (MMR) gene variants as the etiologic basis of Lynch syndrome, there has been tremendous progress in the understanding of the spectrum of cancer risk associated with Lynch syndrome as well as in cancer prevention and risk-reduction strategies. The past few years, in particular, have brought transformative changes in the treatment of Lynch syndrome–associated cancers with immune checkpoint inhibitors. In parallel, advances in next-generation sequencing (NGS) technologies now allow rapid and scalable somatic and germline sequencing that promises to help identify Lynch syndrome in individuals who otherwise lack classic phenotypes. Last, real progress is being made to understand more sophisticated methods of precision cancer prevention, including chemotherapeutic prevention agents (e.g., aspirin) and strategies that leverage the immune system to facilitate primary cancer prevention in otherwise-healthy Lynch syndrome carriers.

Sign in / Sign up

Export Citation Format

Share Document